TINJAUAN INTERAKSI OBAT DALAM TERAPI BRONKHITIS PADA PEDIATRI DI INSTALASI RAWAT JALAN RUMAH SAKIT UMUM DAERAH CILACAP
DOI:
https://doi.org/10.30595/sainteks.v9i1.283Abstract
Bronchitis is a kind of infection which comes from one or more infections that happens in bronchus and it’s caused by many factors. The infection may come from bacteria, allergy, etc. it needs much more medicine for bronchitis medical therapy and it enlarges the possibility for Drug Related Problems (DRPs) to happen. This study is aimed to find out Potential Drug Related Problems on pediatric bronchitis therapy in Rumah Sakit Umum Daerah (RSUD) Cilacap especially drugs interaction. Identification of Potential DRPs adverse drugs reactions (ADR) or drugs interaction. It is a descriptive research that uses data collecting method retrospectively. The research resource is patient medical record. Data analysis is done by comparing the record with releven books (Drug Interaction Fact and Stockley;s Drugs interaction). The research result shows that DRPs happen ADR or drug interaction is 20% from 140 bronchitis cases. based on the result,it can be concluded that there is Potential DRPs on pediatric bronchitis therapy in RSUD Cilacap. It’s Esspesially adverse drugs reactions (ADR) or drugs interaction Keywords: Pediatric, Bronchitis Therapy, Potential DRPs, RSUD Cilacap, Drugs Interaction, Adverse Drugs ReactionReferences
Arif, M. 2008. Kapita Selekta Kedokteran. Jilid 2. Edisi III. Mansjoer, Arif (Eds). Jakarta: Penerbit Media Aesculapius FK. UI
Askgaard D.S., Wilcke T., Døssing M., 1995, Hepatotoxicity caused by the combined action of isoniazid and rifampicin. Thorax . 50. Cit Baxter, K., 2009, Stokley’s Drugs Interaction, London : Pharmaceutical Press
Bennet, P. M., and Brown, M. J., 2003, Clinical Pharmacology, London : Churcil Livingston
Baxter, K., 2009, Stokley’s Drugs Interaction, London : Pharmaceutical Press
Cipole, RJ, Strand, L.M. and Morley, P.C. 1998.pharmaceeutical Care Practice, New York: M.C Graw Hill Companis, Inc,.
Coyle, E.A, dan Prince, R.A,2002,Urinary Tract Infections and Prostatitic, In Dipro J,T,et al, Pharmacotherapy : A Pathophyciologic Approach 5 th Editions, New York: The Mc Graw Hill Companies, Inc.
Greene R. J. and Harris N. D., 2008, Pathology and Therapeutics for Pharmacists A basis for clinical pharmacy practice 3rd Edition, London Pharmaceutical Press.
Katzung, B.G., , 2004. Farmakologi dasar dan Klinik edisi 8. Jakarta Universitas Air Langga : Salemba Medika.
Lullman H., Mohr, K., Hein, L., Bieger, D., 2005, Color Atlas Pharmacology 3rd Edition, New York : thieme
Tatro, D.S. 2006. Drug Interaction Facts. Fifth Edition, Factor and Comparisons, Colifornia: a Walter Klower Company.
Tan, H,T, dan Rahardja, K, 2002, Obat-Obat Penting,Edisi V. Jakarta: PT Elex Media Komputindo Kelompok Gramedia
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
